Management of Diabetic Ketoacidosis in Elderly Type 1 Diabetics

Immediate Diagnosis and Treatment

The American Diabetes Association recommends immediate intensive care unit admission for patients presenting with diabetic ketoacidosis (DKA), requiring insulin infusion, aggressive fluid resuscitation, and electrolyte replacement, with particular attention to life-threatening hypokalemia and metabolic acidosis 1
The clinical presentation of altered mental status, hyperglycemia, metabolic acidosis, hypokalemia, and hyponatremia in a Type 1 diabetic is pathognomonic for DKA, with a confirmed diagnosis based on elevated capillary or serum ketones and bicarbonate <16 mmol/L 1

The American Association of Clinical Endocrinologists recommends admitting patients to the ICU for close metabolic monitoring, fluid and electrolyte replacement, and continuous insulin infusion, with baseline C-peptide and glucose testing to confirm absolute insulin deficiency characteristic of Type 1 diabetes 1
The Endocrine Society suggests starting continuous IV insulin infusion as per DKA protocol, without stopping insulin even if oral intake is poor, as Type 1 diabetics have absolute insulin deficiency and will develop DKA without it 1, 2

The American Diabetes Association recommends that in elderly Type 1 diabetics with organ failure or decreased oral intake, insulin may be reduced but never discontinued, to prevent DKA 2, 3

The American Geriatrics Society suggests providing education on hypoglycemia management, stress dosing, ketone monitoring, and DKA warning signs, which is critical for elderly Type 1 diabetics 1
The International Diabetes Federation recommends targeting glucose 5-10 mmol/L (90-180 mg/dL) as reasonable, but more flexible targets are appropriate if elderly, experiencing frequent hypoglycemia, or has limited life expectancy 1
The American Diabetes Association recommends preventing hypoglycemia as a priority over tight glycemic control in elderly patients with multiple comorbidities 2, 3

The American Diabetes Association warns against discontinuing insulin in Type 1 diabetes, even at end of life, as a small basal dose prevents DKA and maintains comfort 2, 3, 6
The Endocrine Society advises against using sliding scale insulin alone without basal insulin, as this approach is associated with poor outcomes and higher hypoglycemia rates in elderly patients 5
The American Geriatrics Society recommends avoiding premixed insulin formulations in elderly patients, as they have threefold higher hypoglycemia rates compared to basal-bolus regimens 5